Bradley Radoff and Jumana Capital disclosed a joint 7.6% position in Genesco Inc. via 13F filing, marking the second activist entry into the Nashville-based footwear operator in eighteen months. The stock moved 8.2% higher intraday on volume 3.1x the thirty-day average before settling at $32.14, still 41% below the April 2021 peak of $54.87. Genesco closed Friday with a market capitalization of $438 million and trailing twelve-month revenue of $2.27 billion across its Journeys, Schuh, and Johnston & Murphy banners.

The filing names Radoff, previously involved in pushes at mid-cap retail and industrial names, as the operational lead. Jumana Capital, a New York-based fund with $180 million in disclosed U.S. equity AUM, has taken positions in three other sub-$500 million market-cap companies since August. Neither party issued a public letter, but the Schedule 13D language includes standard provisions for board representation discussions and strategic alternative review. Genesco has not responded to the disclosure as of Sunday evening.

The timing reflects structural pressure in teen and young-adult footwear. Genesco's same-store sales fell 4% in the most recent quarter, driven by Journeys mall traffic declines and 12% markdowns to clear seasonal inventory. Operating margin compressed 190 basis points year-over-year to 6.8%, even as the company bought back $22 million in stock during the period. Management guided fiscal 2025 EPS to a range of $4.10 to $4.60, implying a forward P/E of 7.2x at the midpoint—a 34% discount to the sector median. The company carries $187 million in net debt, manageable but limiting flexibility for transformational moves without asset sales.

Activists see three levers. First, a potential separation of Johnston & Murphy, the dress and casual leather line that operates 170 owned stores and generates an estimated $340 million in annual revenue at higher gross margins than the teen banners. Second, accelerated store closures at underperforming Journeys locations, where 68 of 875 locations are either lease-expiring or below breakeven on a four-wall basis. Third, a full sale process, particularly appealing to private equity buyers seeking consolidation plays in specialty retail. Peer transactions in the last sixteen months have cleared at 0.4x to 0.6x trailing revenue multiples, implying a valuation range of $900 million to $1.36 billion for Genesco—roughly double the current market cap.

Operators should track three near-term events. Genesco reports fiscal Q3 earnings on December 5, where management will face questions on capital allocation and strategic review openness. The company's annual meeting is scheduled for late June, giving the activist group six months to negotiate board seats or launch a proxy fight. Comparable-store sales trends through the holiday season, particularly Black Friday weekend performance at Journeys, will either validate or undermine the activist thesis that operational fixes can precede structural moves.

Private equity scanned the Genesco filing within hours. The stock now trades at 1.4x tangible book value with a clean balance sheet post-restructuring and no pension overhang. If same-store sales stabilize by February, the valuation gap narrows before activists need to force anything.